GLPBio

Polyphyllin VI

Catalog No.: GN10249Purity:>98.00%
Polyphyllin VI is an orally active natural saponin that exerts anticancer effects primarily by inducing cell-cycle arrest, apoptosis, and pyroptosis.

Products are for research use only. Not for human use. We do not sell to patients.


Polyphyllin VI
Cas No.: 55916-51-3
10mM (in 1mL DMSO)In Stock
$180.00
1
1mgIn Stock
$42.00
1
5mgIn Stock
$111.00
1
10mgIn Stock
$144.00
1

Citations

No citations are currently available for this product. Below are selected publications citing GlpBio products.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

Polyphyllin VI is an orally active natural saponin that exerts anticancer effects primarily by inducing cell-cycle arrest, apoptosis, and pyroptosis[1][2]. Polyphyllin VI is commonly used in cancer-mechanism studies, especially those focused on cell-death pathways and their associated signaling cascades[3].

In vitro, treatment of glioma cells with Polyphyllin VI (0-8μM; 12-48h) dose-dependently inhibits cell proliferation, blocks cycle at G2/M, suppresses migration, and induces apoptosis and autophagy[4]. Polyphyllin VI (0-30μM; 48h) inhibits U2OS osteosarcoma proliferation, triggers G2/M arrest, collapses mitochondrial membrane potential, and simultaneously evokes caspase-mediated apoptosis[5].

In vivo, Polyphyllin VI (5mg/kg/day; i.p.; 14 days) reversed bleomycin-induced pulmonary fibrosis in C57BL/6J mice, reduced collagen deposition, suppressed α-SMA and vimentin expression, and restored E-cadherin levels[6]. Polyphyllin VI (10mg/kg/day; i.p.; 10 days) increased NLRP3 inflammasome activation and caspase-1-mediated pyroptosis in A549 tumor xenografts of athymic nude mice[7].

References:
[1] Lin Z, Liu Y, Li F, et al. Anti-lung Cancer Effects of Polyphyllin VI and VII Potentially Correlate with Apoptosis In Vitro and In Vivo. Phytother Res. 2015;29(10):1568-1576.
[2] Liu Y, Dong X, Wang W, et al. Molecular Mechanisms of Apoptosis in HepaRG Cell Line Induced by Polyphyllin VI via the Fas Death Pathway and Mitochondrial-Dependent Pathway. Toxins (Basel). 2018;10(5):201.
[3] Wang Y, Huang X, Xian B, et al. Machine learning and bioinformatics-based insights into the potential targets of saponins in Paris polyphylla smith against non-small cell lung cancer. Front Genet. 2022;13:1005896.
[4] Liu W, Chai Y, Hu L, et al. Polyphyllin VI Induces Apoptosis and Autophagy via Reactive Oxygen Species Mediated JNK and P38 Activation in Glioma. Onco Targets Ther. 2020;13:2275-2288.
[5] Yuan YL, Jiang N, Li ZY, et al. Polyphyllin VI induces apoptosis and autophagy in human osteosarcoma cells by modulation of ROS/JNK activation. Drug Des Devel Ther. 2019;13:3091-3103.
[6] Xie Y, Gan C, Liu H, et al. Polyphyllin VI Ameliorates Pulmonary Fibrosis by Suppressing the MAPK/ERK and PI3K/AKT Signaling Pathways via Upregulating DUSP6. Phytother Res. 2024;38(12):5930-5948.
[7] Teng JF, Mei QB, Zhou XG, et al. Polyphyllin VI Induces Caspase-1-Mediated Pyroptosis via the Induction of ROS/NF-κB/NLRP3/GSDMD Signal Axis in Non-Small Cell Lung Cancer. Cancers (Basel). 2020;12(1):193.

Protocol

Cell experiment [1]:

Cell lines

Glioma Cell lines U87, LN229, U251, and U343

Preparation Method

Glioma Cell lines U87, LN229, U251, and U343 were cultured in DMEM medium supplemented with 10% FBS and maintained in an incubator at 37°C, and 5% CO2. Approximately 2000 glioma cells were re-suspended in 100µL of complete medium and cultured in 6-well plates for 24 hrs. The cells were treated with varying concentrations of Polyphyllin VI (0, 2, 4, 6, and 8µM) followed by a 12, 24 and 48 hrs incubation. Thereafter, the cells were treated with the WST-8 reagent from CCK-8 for 2 hrs, then their viability assayed by detecting the absorbance at OD 450nm. Cell apoptosis was analyzed using the Annexin V-FITC Kit. Cell cycle distribution was detected by flow cytometry. Transwell assay was carried out to determine the role of Polyphyllin VI on the invasive ability of glioma cells.

Reaction Conditions

0-8μM; 12-48h

Applications

Polyphyllin VI (0-8μM; 12-48h) dose-dependently inhibits cell proliferation, suppresses migration, and induces apoptosis in glioma cells.

Animal experiment [2]:

Animal models

C57BL/6 mice

Preparation Method

C57BL/6 mice were first anesthetized with 5mg/mL pentobarbital sodium. Then, 100μL of normal saline containing BLM sulfate(2mg/kg) was directly injected into the trachea of C57BL/6J mice. For the therapeutic experiment, the mice were randomly categorized into two groups on the seventh day following BLM modeling: the BLM+solvent (dimethyl sulfoxide: polyethylene glycol 400: normal saline=5:45:50) group and the BLM+Polyphyllin VI (5mg/kg/day) group. All mice were injected intraperitoneally with PPVI for 14 days, during which the mice's weight was measured every 3 days. Then the mice were sacrificed for tissue sample collection, and the weight of the lungs was recorded. Histopathological and immunohistochemical (IHC) tests were conducted on a lung excised from the left and soaked in 4% paraformaldehyde.

Dosage form

5mg/kg/day; i.p.; 14 days

Applications

Polyphyllin VI reversed bleomycin-induced pulmonary fibrosis in C57BL/6J mice, reduced collagen deposition, suppressed α-SMA and vimentin expression, and restored E-cadherin levels.

References:
[1] Liu W, Chai Y, Hu L, et al. Polyphyllin VI Induces Apoptosis and Autophagy via Reactive Oxygen Species Mediated JNK and P38 Activation in Glioma. Onco Targets Ther. 2020;13:2275-2288.
[2] Xie Y, Gan C, Liu H, et al. Polyphyllin VI Ameliorates Pulmonary Fibrosis by Suppressing the MAPK/ERK and PI3K/AKT Signaling Pathways via Upregulating DUSP6. Phytother Res. 2024;38(12):5930-5948.

Product Documents

Purity:>98.00%Appearance:A solid

Chemical Properties

CAS No.
55916-51-3
Chemical Name
Chonglou saponin VI
SMILES
O[C@@H]([C@@H](O)[C@H]1O)[C@]([H])(O[C@H]2[C@@](O[C@H]3CC4=CC[C@]([C@](C[C@@](O[C@]5(OC6)CC[C@H]6C)([H])[C@]7(O)[C@@H]5C)([H])[C@@]7(CC8)C)([H])[C@@]8([H])[C@]4(CC3)C)([H])O[C@H](CO)[C@@H](O)[C@@H]2O)C[C@@H]1C
Molecular Formula
C39H62O13
Molecular Weight
738.91
Solubility
≥ 73.9mg/mL in EtOH with gentle warming
Storage
Store at -20℃
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for Polyphyllin VI

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%